ROYALTY PHARMA PLC's ticker is RPRX and the CUSIP is G7709Q104. A total of 331 filers reported holding ROYALTY PHARMA PLC in Q4 2022. The put-call ratio across all filers is 0.58 and the average weighting 0.5%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2023 | $11,558,329 | -16.4% | 404,987 | -5.8% | 0.00% | -20.0% |
| Q2 2023 | $13,820,448 | +99.5% | 429,874 | +145.4% | 0.01% | +66.7% |
| Q4 2022 | $6,928,459 | +10.9% | 175,138 | +16.3% | 0.00% | 0.0% |
| Q3 2022 | $6,245,000 | +7.1% | 150,643 | +10.4% | 0.00% | 0.0% |
| Q2 2022 | $5,832,000 | +4.4% | 136,489 | -4.6% | 0.00% | 0.0% |
| Q1 2022 | $5,584,000 | -12.4% | 143,058 | -9.1% | 0.00% | 0.0% |
| Q4 2021 | $6,371,000 | +3.1% | 157,427 | -6.4% | 0.00% | 0.0% |
| Q3 2021 | $6,179,000 | +19.7% | 168,260 | +34.2% | 0.00% | 0.0% |
| Q2 2021 | $5,162,000 | -0.3% | 125,379 | +1.6% | 0.00% | 0.0% |
| Q1 2021 | $5,178,000 | -28.1% | 123,436 | -12.1% | 0.00% | -40.0% |
| Q4 2020 | $7,205,000 | +25.7% | 140,391 | +7.3% | 0.01% | 0.0% |
| Q3 2020 | $5,730,000 | – | 130,831 | – | 0.01% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| SIGULER GUFF ADVISERS, LLC | 6,761,970 | $338,436,000 | 92.73% |
| Vantage Consulting Group Inc | 21,477,282 | $1,074,938,000 | 87.53% |
| Memorial Sloan Kettering Cancer Center | 3,565,887 | $178,473,000 | 75.56% |
| HARVARD MANAGEMENT CO INC | 14,690,780 | $735,274,000 | 39.88% |
| ROBERT WOOD JOHNSON FOUNDATION | 3,958,498 | $1,981,228,000 | 21.69% |
| Brown University | 381,759 | $19,107,000 | 13.82% |
| Overbrook Management Corp | 778,511 | $38,964,000 | 9.50% |
| ADAGE CAPITAL PARTNERS GP, L.L.C. | 38,714,280 | $1,937,650,000 | 4.22% |
| Lagoda Investment Management, L.P. | 96,885 | $4,849,000 | 2.61% |
| HealthCor Management, L.P. | 1,339,530 | $67,043,000 | 2.58% |